fda and tirzepatide shortage is on the list Compounders protest as removes off Tirzepatide may not be removed – fda removes tirzepatide from shortage

Circ Heart Fail 10:e004551

Food and Drug Administration) This is why patients should avoid one-click weight loss shortcuts and instead work with a qualified medical team that can evaluate risks, review labs, monitor progress, and adjust the plan appropriately

Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates

What the Oxford study revealed about regain speed A study from the University of Oxford published in early 2026 compared weight regain after stopping medications versus ending behavioral weight loss programs